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Summary 
Differentiation of most T  lymphocytes occurs within the thymus and is characterized by vari- 
able expression of CD4/CD8 coreceptor molecules, increased surface density of T  cell antigen 
receptor (TCtk) ot[3 proteins, and decreased expression of glycan chains recognized by the ga- 
lactose-specific lectin peanut agglutinin (PNA). Although appreciated for several  decades that 
PNA agglutination is useful for the physical separation of immature and mature thymocyte sub- 
populations, the identity of specific  PNA-binding glycoproteins expressed on immature thy- 
mocytes remains to be determined. In the current report, we studied the expression of PNA- 
specific  glycans on immature and mature T  cells and used lectin affinity chromatography and 
immunoprecipitation techniques to characterize PNA-binding glycoproteins on thymocytes. 
Our data demonstrate that PNA-specific glycans  are  localized on a relatively small subset of 
thymocyte surface  proteins,  several  of which were  specifically  identified, including CD43, 
CD45, and suprisingly, CD8 molecules. CD80t and CD8o~' proteins bound to PNA in the ab- 
sence of CD813 expression showing that O-glycans on CD813 glycoproteins are not necessary 
for PNA binding and that glycosylation of CDSot and CD8e~'  proteins proceeds effectively in 
the absence of CD813. Finally, we demonstrate that PNA binding of CD8 is developmentally 
regulated by sialic acid addition as CD8 proteins from mature T cells bound to PNA only after 
sialidase treatment. These studies identify CD8 as a PNA receptor molecule on immature thy- 
mocytes and show that PNA binding of CD8 on immature and mature T  ceils is developmen- 
tally regulated by sialic acid modification. 
M 
ost T cells of the immune system differentiate within 
the thymus by a highly ordered process referred to as 
thymic selection (1, 2). The maturation status ofthymocyte 
subpopulations is most often evaluated by their variable  ex- 
pression  of CD4/CD8  coreceptor  molecules and surface 
density of eli3 TCI< (T cell antigen receptor) proteins. By 
these  criteria,  three  major  thymocyte subpopulations  are 
identified within the thymus which exemplify the proges- 
sion  of thymocytes along  the  CD4/CD8  developmental 
pathway: (a) immature CD4-CD8-  (double-negative) thy- 
mocytes,  which  express  no/low  surface  density  of oq3 
TCP.;  (b)  immature  CD4+CD8 +  (double-positive)  thy- 
mocytes,  which  express  no/low  surface  density  of eq3 
TCR; and (c) mature CD4+CD8 -  and CD4-CD8 + (single 
positive)  thymocytes, both of which express  high surface 
density of ot~ TCP.  (1,  2).  The predominant thymocyte 
subpopulation  is  the  immature  CD4+CD8 +  thymocyte 
subset, which accounts for ".,85% ofT ceils within the thy- 
mus (1, 2). 
The  characterization  of immune  ceil  subsets  has  been 
greatly facilitated by the  use  of lectins,  which  recognize 
specific  glycan  residues  attached  to  lipid  molecules  or 
polypeptide chains (3, 4). Approximately two decades ago, 
tkeisner et al. noted that immature and mature thymocyte 
subpopulations were easily separated based on their differ- 
ential agglutination with the galactose-binding lectin pea- 
nut agglutinin (PNA), specific for Gal[31,3GalNAc  residues 
attached  in  O-linkage  to  proteins  (5,  6).  Expression  of 
PNA-specific glycans is quantitatively regulated during T 
cell development with immature CD4+CD8 + thymocytes 
expressing significant amounts of PNA-specific glycans on 
their cell surfaces relative to mature T  cells, which express 
little, if any, surface PNA-specific glycans (4, 5). 
Glycoproteins  bearing  O-linked  Gal~I,3GalNAc  gly- 
cans can be modified by numerous glycosyltransferases  lo- 
calized in the  Golgi complex,  including Gal[31,3GalNAc 
cx2,3 O-linked sialyltransferase  (ST) and GalNAc cx2,6 ST, 
which transfer sialic acid (SA) to Gal and GalNAc residues, 
respectively,  (7). Surface density of PNA-specific  glycans 
on developing thymocytes is inversely correlated with the 
expression  of (*2,3 O-linked  ST  (7), suggesting that de- 
creased expression of PNA-specific glycans on mature thy- 
mocytes results from increased sialylation of O-linked gly- 
coproteins which "mask" their recognition by PNA (4, 7). 
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lated expression ofPNA-specific glycans on T  lymphocytes 
is unknown, but has been suggested to play a role in signal 
transduction  during thymic selection  (7)  and the retention 
of immature  thymocytes  within  the  thymic  cortex,  pre- 
venting their premature escape into the periphery (4,  7). 
Despite the widespread use ofPNA lectins in the distinc- 
tion  of immature  and  mature  thymocyte  subpopulations, 
virtually nothing is known regarding the identity of poly- 
peptides  modified by PNA-specific glycans on developing 
T  cells.  Although previous studies have reported the isola- 
tion of PNA-binding glycoproteins from both human and 
mouse  thymocytes  (8-12),  the  identity  of specific  PNA- 
binding glycoproteins on thymocytes remains  to be estab- 
lished.  Because CD43 and CD45 molecules are highly ex- 
pressed on thymocytes and migrate with similar mobility as 
proteins  recognized  by  PNA,  it  has  been  suggested  that 
CD43  and  CD45  are the predominant  PNA-binding gly- 
coproteins expressed on immature thymocytes (9-12). P,.e- 
latedly,  the  comigration  of PNA-binding  molecules  with 
Thy-1  proteins  led  to  the  proposition  that  Thy-1  was  a 
major  PNA-binding glycoprotein on  thymocytes  (9,  10); 
subsequent  studies  demonstrated,  however,  that  Thy-1 
proteins do not contain O-linked glycans (13), making the 
interaction of Thy-1 with PNA somewhat enigmatic. 
In the current report we studied the expression of PNA- 
specific glycans on developing thymocytes. Approximately 
8-10  PNA-binding glycoproteins were isolated from thy- 
mocytes using lectin affinity chromatography and immuno- 
precipitation  techniques,  several of which were specifically 
identified,  including  CD43,  CD45,  and,  unexpectedly, 
CD8.  Moreover,  we  show  that  CD8oL,  CD8cx'  proteins 
bind to PNA in the absence of CD813 and that PNA bind- 
ing of CD8 is developmentally regulated on immature and 
mature T  cells by sialic  acid modification. 
Surface biotin-labeling, Lectin Affinity Chromatography, lmmunopre- 
cipitation, and Gel Electrophoresis.  Cells  were  washed  2￿  in  cell 
wash buffer (PBS containing 1 n-flVi MgC12 and 100 fxM CaC12)  , 
resuspended  in wash buffer containing 1 mg/ml  sulfo-NHS bi- 
otin (Pierce Chem. Co., Rockford, IL), and incubated at 4~  for 
30 min. Labeling was terminated by washing in buffer containing 
25  mM lysine.  Cells were solubilized  in  1% NP-40 lysis buffer 
and lysates were precipitated  with  lectins  conjugated to agarose 
beads  (EY Laboratories)  for 3 h at  4~  according to established 
methods  (19). Immunoprecipitation and gel  electrophoresis  was 
performed  as previously described  (16). Biotin-labeled  proteins 
were visualized  by chemiluminescence, performed according to 
manufacturer's  instructions  (Renaissance  Chemilunfinescence  Re- 
agent; Dupont, NEN, Boston, MA). 
Sialidase Digestion.  Cells were washed  2￿  in ILPMI medium 
without FCS, resuspended in RPMI at a density of 1 ￿  10  ~' cells/ml, 
and incubated at 37~  for 30 rain in the presence of 1(t--2(} mU 
ofsialidase  (Vibrio cholerae);  (Boehringer Mannheim, Indianapo- 
lis, IN). Sialidase treatment was terminated by washing cells 25< 
in  RPMI  containing  10%  FCS.  Viability  was  identical  in  un- 
treated  and sialidase treated  groups (data not shown). 
Results 
Su~ace Expression  of PNA-specific Glycans on Immature  and 
Mature  T  Cell Subpopulations.  Initially,  we  examined  the 
surface density ofPNA-specific glycans on various T  cell sub- 
populations by staining with fluorescein (FITC)-labeled PNA. 
Significant amounts of PNA-specific glycans were expressed 
on thymocytes (Fig.  1,  1st column, top panel), the vast ma- 
jority of which were localized on the immature CD4+CD8 + 
thymocyte subpopulation  (Fig.  1,  1st column,  2nd panel),  as 
expected.  In contrast,  low levels  of PNA-specific glycans 
were  present  on  mature,  dexamethasone-resistant  thy- 
mocytes and mature splenic T  cells in the periphery (Fig.  1, 
1st column,  3rd and 4th panels,  respectively).  Sialidase  treat- 
Materials  and Methods 
Animals and Cell Preparation.  C57BL/6 (B6) mice 6-8 weeks 
of age were obtained from the Jackson Laboratory (Bar Harbor, 
ME).  CD8c~ deficient (CD8-/-)  mice (H-2  b haplotype; refer- 
ence 14) were kindly provided by Drs. Tak Mak (Ontario Cancer 
Institute,  Toronto)  and  Dinah  Singer  (NIH,  Bethesda,  MD); 
CD8(3-deficient  (CD813-/-)  mice  (H-2  b haplotype;  reference 
15) were kindly provided by Drs. Tak Mak (Ontario Cancer In- 
stitute,  Toronto) and Alfred Singer  (NIH, Bethesda,  MD). CD4 + 
C1)8 §  thymocytes,  dexamethasone-resistant  thymocytes,  and 
splenic T cells were isolated as previously reported (16). 
Reagents and Antibodies.  Immobilized and fluorescent-labeled 
lectins were purchased from EY Laboratories (San Diego, CA) and 
Sigma Chemical Co. (St. Louis, MO). The following nkAbs were 
used in this study: M1/9.3.4 anti-CD45 mAb (17); $7 anti-CD43 
mAb  (18); (PharMingen,  San  Diego,  CA);  53-6.7  anti-CD8c~ 
mAb, (PharMingen);  and 53-5.8 anti-CD8]3 mAb (PharMingen). 
Cells were analyzed  on FACSTAR  |  and FACSCAN  |  (Becton 
Dickinson,  Mountain  View,  CA)  flow cytometers. All  fluores- 
cence  data  were  collected  using  logarithmic  amplification  on 
50,000 viable cells as detemlined by forward light scatter intensity 
or propidium iodide exclusion. 
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Figure 1.  Surface  expression of PNA-specific glycans  on inmlature and 
mature T cells. Mock-treated and sialidase-treated T cells were stained 
with FITC-conjugated PNA. One color histograms also include negative 
control staining (shaded  curve). 
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thymocytes. Thymocytes were biotin labeled, solubilized in 1% NP-40, 
and  lysates precipitated with  PNA affinity matrices. Where  indicated, 
PNA-bound material was eluted by addition of  200 mM galactose. Galac- 
tose eluates were precipitated with indicated mAbs specific for immune 
receptor proteins. Precipitates were analyzed on one-dimensional 10% 
SDS-PAGE gels under reducing conditions and visualized by chemilumi- 
nescence techniques. The positions of CD8, CD43, and CD45 proteins 
are indicated; addition bands in anti-CD43 precipitates represent nonspe- 
cific proteins which were also present in control (no lysate) precipitates 
(data not shown). 
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Figure 3,  Expression  of  PNA-binding 
proteins  on  thymocytes of WT  and 
CD8-/-  mice. (.tt) Thymocytes from 
wild-type  (WT) and  CD8ot-deficient 
(CD8-/-)  mice were biotin labeled, 
solubilized in  1%  NP-40,  and  lysates 
precipitated with PNA affinity matrices 
and anti-CD8 rnAb. Precipitates were analyzed  on one-dimensional 10% 
SDS-PAGE gels under reducing conditions and visualized by chemilumi- 
nescence techniques. The positions of CDS, CD43, and CD45 proteins 
are indicated; * denotes an unknown 55-kD protein that coprecipitates 
with CD8; unidentified proteins present in PNA precipitates migrating at 
~65 and 150 kD are denoted p65 and p150, respectively. (B) WT thy- 
mocytes (solid line) and CD8~x-deficient (CD8-/-)  thymocytes (dashed 
line) were stained with  FITC-conjugated PNA.  One  color histograms 
also include negative control staining (shaded  curve). 
ment  significantly  increased  expression  of  PNA-specific 
glycans on mature T  cells to similar levels observed on sial- 
idase-treated  CD4+CD8 +  thymocytes,  which  also  ex- 
pressed higher levels of PNA-specific glycans after sialidase 
treatment (Fig.  1, 2nd column). Taken together, these data 
demonstrate  that  expression  of  PNA-specific  glycans  is 
quantitatively  regulated  during  T  cell  development  with 
immature  CD4+CD8 + thymocytes expressing high surface 
density  of PNA-specific  glycans  relative  to  mature  dexa- 
methasone-resistant  thymocytes  and  splenic  T  cells.  Fur- 
themlore, these data show that differential expression of  PNA- 
specific glycans on various T  cell subpopulations is regulated 
by  posttranslational  modification  of  galactose-containing 
glycans by sialic  acid addition. 
Identification of Specific PNA-binding Glycoproteins on Imma- 
ture Thymocytes.  To identify specific PNA-binding glyco- 
proteins  expressed  on  immature  thymocytes,  cells  were 
surface-labeled,  solubilized  in  1%  NP-40,  and lysates pre- 
cipitated  with  a PNA affinity matrix.  As shown  in  Fig.  2, 
~8-10  molecular species were visualized in PNA precipi- 
tates  of thymocyte tysates,  with  molecular masses  ranging 
from ~25-200  kD,  (Fig.  2).  Several  proteins  precipitated 
by  PNA  matrices  migrated  with  similar  mobility  as  im- 
mune  receptor  proteins  precipitated  by specific  mAb,  in- 
cluding CD45 proteins,  CD43 proteins,  and CD8 proteins 
(Fig.  2).  PNA precipitation  of unseparated  thymocyte ly- 
sates  and  purified  CD4+CD8 +  thyrnocytes  was  identical 
(data not shown), in agreement with our previous findings 
in  Fig.  1 that the vast majority of thymocyte PNA recep- 
tors are localized on the CD4+CD8 + suhpopulation. Bind- 
ing  of thymocyte  surface  proteins  to  PNA  matrices  was 
specific  in  that  the  vast  majority  of thymocyte molecules 
precipitated  by PNA were  not isolated  on lectin  matrices 
specific for sialic  acid-containing glycans and splenic T  cell 
surface proteins were not bound by PNA (data not shown). 
To confirm the identity of individual PNA-binding glyco- 
proteins on thymocytes, glycoproteins bound to PNA ma- 
trices were eluted with 200 mM galactose and precipitated 
with  mAbs specific for various  immune  receptor proteins. 
As  demonstrated,  CD8,  CD43,  and  CD45  proteins  were 
effectively recaptured  from galactose  eluates  of PNA pre- 
cipitates  by immunoprecipitation  with  specific  n~b  (Fig. 
2).  These studies  directly identify CD8,  CD43,  and CD45 
molecules as PNA-binding glycoproteins expressed on thy- 
mocytes.  The  identity  of other  thymocyte  PNA-binding 
glycoproteins remains  to be  established,  but as determined 
by  precipitation/recapture  experiments  do  not  represent 
Thy-1,  TCR,  CD4,  CD28,  or  major  histocompatibility 
class  I proteins  (W. Wu and K.P.  Kearse,  unpublished ob- 
servations). 
Binding of CD8 Proteins to PNA A~nity Matrices.  Because 
of the importance  of CD8 molecules in immune function, 
the binding of thymocyte CD8 proteins  to PNA matrices 
was  evaluated  in  greater  detail.  CD8  molecules  are  ex- 
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linked dimers of CD8ot-CD8]3 and CD8od-CD8]3 proteins 
(27); CDSed  is a splice variant of CDScx, lacking the cyto- 
plasmic tail (20). To confirm our results on precipitation of 
CD8 by PNA affini  W matrices, we examined expression of 
PNA-binding  glycoproteins  on  thymocytes  from  mice 
containing a targeted disruption  of the CD8ot gene; in the 
absence  of CDSo~ expression  CD8[3 proteins  fail  to  egress 
the ER,  and thus are not expressed on the cell surface (14, 
20). As is evident, CD8 proteins were present in PNA pre- 
cipitates ofwild-wpe (WT) thymocytes but not CD8-defi- 
cient  (CD8-/-)  thymocytes  (Fig.  3,  A).  In  contrast, 
equivalent  amounts  of remaining  PNA-binding  proteins 
were  present  in both lysates,  including a  65-  and  150-kD 
protein (designated p65 and p150, respectively) and CD43, 
CD45  molecules  (Fig.  3, A).  Interestingly,  an unidentified 
protein of 55kD (*) was present in anti-CD8 precipitates  of 
WT  lysates,  which was also visible in  PNA precipitates  of 
WT lysates, but not CD8-/-  lysates  (Fig. 3, A). Expres- 
sion of PNA-specific glycans was decreased  on CDS-/- 
thymocytes relative  to WT  thymocytes (Fig.  3,  B),  show- 
ing that CD8 proteins  (and/or molecules coexpressed with 
CDS) significantly contribute to the total surface density of 
PNA-specific glycans expressed on immature thymocytes. 
Recent studies by Casabo  et al.  have shown that CD8]3 
proteins  are  differentially  glycosylated  on  immature  and 
mature  T  cells,  with  O-linked  glycans  on  thymocyte 
CD8]3 proteins being hyposialylated relative to CD8]3 pro- 
teins  expressed  on  mature  T  cells  (21).  To  determine  if 
CD8c~,  CD8c~'  proteins  bound  to  PNA effectively in  the 
absence of CD8]3,  experiments  were performed using thy- 
mocytes from mice containing a targeted disruption  of the 
CD8~  gene  (15);  CD8ot proteins  are  efficiently  expressed 
Figure 5.  PNA binding of CD8 is developmentally  regulation by sialic 
acid modification. Splenic T cells were biotinylated, mock treated or di- 
gested with sialidase, solubilized in  l% NP-40, and lysates precipitated 
with anti-CD8 mAb or PNA. PNA-bound material was eluted by addi- 
tion of 200 mM galactose and eluates precipitated with anti-CD8 mAb. 
Precipitates were analyzed  on one-dimensional 13% SDS-PAGE gels un- 
der reducing conditions and visualized by chemiluminescence techniques. 
The positions of CD8 proteins are indicated. 
on the cell surface in the absence of partner CD813 proteins 
as disulfide-linked homo/heterodimers of CD8~x and CDS~x' 
(15, 20). As shown in Fig. 4, CD8 molecules on CDB~-/- 
thymocytes  were  efficiently  captured  by  PNA  precipita- 
tion,  as  were  remaining  PNA-binding  proteins  (Fig.  4). 
These  data show that  CDS~x,  CDSot' proteins  bear  PNA- 
binding  O-linked  glycans and  that  glycosylation and  pro- 
cessing of CD8et,  CD8ot' proteins  occurs efficiently in the 
absence  of CD8~  expression.  Interestingly,  fewer 55*  kD 
proteins  were  present  in  PNA precipitates  of CD8~-/- 
thymocytes relative  to WT  thymocytes  (Fig.  4),  a  finding 
which was also observed in anti-CD8& precipitates  of WT 
and CD8]3-/-  thymocyte lysates  (W. Wu and K.P. Kearse, 
unpublished  observations).  The significance of this  finding 
is  unclear,  but  suggests  that  expression  of PNA-binding 
55*-kD  proteins  on thymocytes may be  linked  to  expres- 
sion of CD8]3 gene products. 
Finally,  we  compared the  PNA binding of CD8  mole- 
cules on mature T  cells  before and after sialidase  treatment. 
As shown  in  Fig.  5,  CD8  molecules  from sialidase-treated 
splenic T  cells nfigrated with slightly increased mobility rel- 
ative to CD8 from mock treated T  cells  (Fig. 5), due to re- 
moval of sialic  acid residues  from glycan chains.  Most im- 
portantly,  these  data  demonstrate  that  CD8  proteins  from 
sialidase-treated  splenic  T  cells,  but  not  mock  treated  T 
cells,  were effectively bound by PNA (Fig. 5).  No increase 
in  PNA  binding  of CD8  molecules  from  immature  thy- 
mocytes  was  observed  after  sialidase  treatment  (data  not 
shown). Thus, we conclude that PNA binding of CD8 on 
immature  and mature  T  cells  is developmentally regulated 
by sialic  acid addition. 
Figure 4.  CI)8~x  and CD8~' proteins bind to PNA in the absence of 
CD813.  Thymocytes  from wild-type (W/)  and  CD8[~ deficient 
(CD8~-/-) mice were biotin labeled, solubilized in 1% NP-40, and ly- 
sates precipitated with PNA affinity matrices. Precipitates were analyzed 
on one-dimensional 10% SDS-PAGE  gels under reducing conditions and 
visualized by  chemiluminescence techniques. The  positions of PNA- 
binding proteins are indicated as in Fig. 3 A. 
Discussion 
The  present  study has  specifically identified  several  im- 
portant  imnmne  receptor proteins  as  PNA-binding glyco- 
proteins  on immature thymocytes. In agreement with pre- 
vious  suggestions,  our  data  provide  direct  evidence  that 
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include  CD43  and CD45  proteins  (8,  10,  11).  Unexpect- 
edly, we found that CD8 proteins were among the subset 
of PNA-binding  glycoproteins  expressed  on  developing 
thymocytes, which most likely represent the lower molec- 
ular weight species previously believed to be Thy-1 (9, 10). 
Recent studies by Casabo et al.  demonstrated that  CD813 
proteins  are  differentially  glycosylated  on  immature  and 
mature T  cells, with O-linked glycans on thymocyte CD813 
proteins being hyposialylated relative to CD813 proteins ex- 
pressed on mature T  cells (21).  We found that CD8ot mol- 
ecules were efficiently isolated on PNA affinity matrices in 
the absence of CD813  gene expression, indicating that de- 
velopmentally  regulated  PNA-binding  of  CD8  proteins 
does  not  result  from  variable  addition  of sialic  acid  to 
CD813  proteins  on  immature  versus  mature  T  cells.  Al- 
though  not  directly determined  in  this  study,  we  believe 
that binding of thymocyte CD8 proteins to PNA matrices 
is mediated via recognition of CD8ci gene products, which 
like  CD8~,  contain  O-linked glycans (20).  However, we 
have also  considered the possibility that CD8 proteins are 
indirectly bound to PNA affinity matrices via their associa- 
tion with unknown  molecules containing  O-glycans, that 
are  not  efficiently  labeled  by  biotinylation.  Experiments 
designed to address these issues are currently in progress. 
The  functional  significance  of regulated  expression  of 
PNA-specific  glycans on  developing T  cells  is  unknown. 
Current hypotheses suggest that masking/unmasking of ga- 
lactose-containing  glycans  on  thymocytes  regulates  their 
egress from the thymic cortex to the medulla (4) or may be 
important  in regulating signal transduction  during  thymic 
selection  (7).  Galactose-specific lectins  have been isolated 
from  thymic  epithelium  that  agglutinate  immature  thy- 
mocytes  but  not  mature  thymocytes  (22),  which  could 
conceivably play a role in intrathymic trafficking of devel- 
oping  thymocytes.  More  recently,  Baum  et  al.  reported 
that  human  thymic  epithelial  cells  synthesize  endogenous 
gactose-binding lectins  (galectin-1)  that  bind  to  oligosac- 
charides  on  thymocytes  (23),  suggesting  that  interactions 
between  thymocytes  and  thymic  epithelial  cells  may  be 
regulated by expression  of glycans on  the  thymocyte cell 
surface.  Other potential  counterreceptors  that may recog- 
nize PNA-binding oligosaccharides in vivo include the en- 
dogenous lectin CD23, which recognizes Gal-GalNAc sac- 
charides  (24).  Regarding the role of PNA-specific glycans 
in thymic signal transduction,  the importance of sialic acid 
containing N-linked glycans in engagement of CD45 pro- 
teins by CD22 ligands has been established (25,  26). Thus, 
it is conceivable that regulated addition of sialic residues to 
O-linked glycans of CD45 proteins might be of similar sig- 
nificance  for  their  recognition  by  as  yet  undetermined 
ligands within the thymus. Similarly, given the recently ap- 
preciated role of CD43 in T  cell activation (27,  28) and its 
extensive modification by O-linked glycans, it is reasonable 
to speculate that differential processing of O-linked sugars 
on CD43 proteins may affect delivery of intracellular acti- 
vation signals to developing thymocytes. 
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